Patent · US Active

Characterization of granulocytic ehrlichia and methods of use

US8461323B2 · kind B2 · utility

2Cited by
10References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2012
Grant dateJun 11, 2013
Priority date
Expiry dateJan 9, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, in general, to polypeptides having antigenic epitopes from granulocytic ehrlichia (GE) proteins and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.